Mera-med.ru

Онкология
- Лечение онкологии
- Меланома
- Лейкоз
- Острый лейкоз
- Хронический лейкоз
- Лейкоз крови
- Рак



















онколог дермотолог

In spite of the fact that анастрозол has shown the superiority before тамоксифеном, last while remains the standard адъювантной гормонотерапии (term of reception - 5 years) as time of supervision in research АТАС, equal 33 months, is, in opinion of the majority of the experts, insufficient to recommend анастрозол as the standard адъювантной эндокринотерапии. Подробнее...

The data of the first intermediate analysis of results of research BCRIG01 are published, in which comparison of efficiency of standard mode FAC (500/50/500) with a таксан-containing mode (with inclusion Таксотера) ТАС (75/50/500 (1) is lead{carried out}. Both modes were used with an interval of 3 weeks in quantity{amount} of 6 rates. This first published research estimating a role доцетаксела (Таксотера) in адъювантной of therapy of a cancer dairy железы. Earlier in two other researches (С9344 and В30) the role паклитаксела has been investigated, and one of them (С9344) has shown increase безрецидивной and the general{common} survival rate at patients with рецептороотрицательными tumours at use паклитаксела is consecutive with a mode the EXPERT. Подробнее...